| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/12/2011 | EP2271321A1 Pharmaceutical composition 271 |
| 01/12/2011 | EP2271320A1 Raloxifene pharmaceutical formulations |
| 01/12/2011 | EP2271318A1 Pharmaceutical depot comprising n-{5- t (cyclopropylamino) carbonyl]-2-methylphenyl}-3-flu0r0-4- (pyridin-2-ylmethox y) benzamide |
| 01/12/2011 | EP2271317A1 Method for manufacturing acid pellets |
| 01/12/2011 | EP2271316A2 Fenofibrate dosage forms |
| 01/12/2011 | EP2271315A2 Novel solid forms of bendamustine hydrochloride |
| 01/12/2011 | EP2271314A2 Compositions and methods for the preparation of nanoemulsions |
| 01/12/2011 | EP2271218A1 Use and composition for treating dementia |
| 01/12/2011 | EP2271215A1 Storage-stable polymaleimide prepolymer compositions |
| 01/12/2011 | EP2271213A1 Methods for treating a condition characterized by dysfunction in protein homeostasis |
| 01/12/2011 | EP2271204A2 Dog pheromone formulation and delivery system |
| 01/12/2011 | EP2192896B1 Carbonylamino derivatives useful for the treatment of inflammatory bowel disease |
| 01/12/2011 | EP2190827B1 N-benzyl-n'-arylcarbonylpiperazine derivatives as lxr modulators |
| 01/12/2011 | EP2183250B1 Naphthyridine derivatives as potassium channel modulators |
| 01/12/2011 | EP2173749B1 2-oxo-2- (2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl) -acetamide derivatives and related compounds as antifungal agents |
| 01/12/2011 | EP2139866B1 Crystalline 1-(cyclohexyloxycarbonyloxy) ethyl 1-((2'-cyanobiphenyl-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate and a process for its preparation |
| 01/12/2011 | EP2129368B1 Combination for use in the treatment of inflammatory disorders |
| 01/12/2011 | EP2094677B1 Thiadiazole derivatives for the treatment of neuro-degenerative diseases |
| 01/12/2011 | EP2094308B1 Stable parenteral formulation containing a rsv inhibitor of a benzodiazepine structure |
| 01/12/2011 | EP2089368B1 Diaminocyclohexane and diaminocyclopentane derivatives |
| 01/12/2011 | EP2081890B1 Arylsulfonyl pyrrolidines as 5-ht6 inhibitors |
| 01/12/2011 | EP2012764B1 Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and paracetamol |
| 01/12/2011 | EP2004157B1 Use of gpr119 receptor agonists for increasing bone mass and for treating osteoporosis, as well as combination therapy relating thereto |
| 01/12/2011 | EP1998620B1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues |
| 01/12/2011 | EP1987006B1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 01/12/2011 | EP1943242B1 Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists |
| 01/12/2011 | EP1938808B1 Preparation for external use comprising tamsulosin |
| 01/12/2011 | EP1896435B1 Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors |
| 01/12/2011 | EP1869001B1 Substituted tetrahydroisochinolines as mmp inhibitors, related production method and use as medicine |
| 01/12/2011 | EP1863819B1 Diazabicyclic aryl derivatives and their use as chinolinergic ligands at the nicotinic acetylcholine receptors |
| 01/12/2011 | EP1827438B1 Pyridine derivatives for inhibiting human stearoyl-coa-desaturase |
| 01/12/2011 | EP1802616B1 Novel azabicyclic aryl derivatives and their medical use |
| 01/12/2011 | EP1797062B1 Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors |
| 01/12/2011 | EP1788980B1 Multi-functional biocompatible coatings for intravascular devices |
| 01/12/2011 | EP1778289B1 Carrier for enteral administration |
| 01/12/2011 | EP1686993B1 Virucidal activities of a composition comprising cetylpyridinium chloride and citric acid |
| 01/12/2011 | EP1682138B1 Heterocyclic inhibitors of mek |
| 01/12/2011 | EP1670784B1 Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists |
| 01/12/2011 | EP1603888B1 2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazoline-4-yl) acetic acids as anti-viral agents, especially against cytomegalo viruses |
| 01/12/2011 | EP1583541B1 Compounds and methods for increasing neurogenesis |
| 01/12/2011 | EP1560580B1 Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors |
| 01/12/2011 | EP1517907B1 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 01/12/2011 | EP1490357B1 Toluene solvate of darifenacin |
| 01/12/2011 | EP1439863B1 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 01/12/2011 | EP1401458B1 Composition consisting of phy906 and chemotherapeutic agents |
| 01/12/2011 | EP1334103B1 Methods for treatment of disease-induced peripheral neuropathy and related conditions |
| 01/12/2011 | EP1254951B1 Molecule transferring device, auxiliary for molecule transferring device, and molecule transferring method |
| 01/12/2011 | EP0993829B1 Transdermal preparation containing serotonin receptor antagonist |
| 01/12/2011 | EP0821736B1 Bacteriocins |
| 01/12/2011 | CN201701514U Tablet capsule containing roxithromycin tablets and ambroxol hydrochloride tablets |
| 01/12/2011 | CN201701513U Tablet capsule filled with cefalexin tablets and ambroxol hydrochloride tablets |
| 01/12/2011 | CN201701512U Tablets capsule containing loratadine tablets and ambroxol hydrochloride tablets |
| 01/12/2011 | CN201701511U Tablet capsule filled with amoxicillin tablets and ambroxol hydrochloride tablets |
| 01/12/2011 | CN201701510U Tablet capsule filled with salbutamol sulfate tablet and ambroxol hydrochloride tablet |
| 01/12/2011 | CN201700858U Height adjustable healthcare pillow |
| 01/12/2011 | CN1985994B Improved enteric medicine composition with mycophenolate |
| 01/12/2011 | CN1985927B Medicine composition for treating hepatic disease mainly |
| 01/12/2011 | CN1981817B Chinese-medicinal composition for treating cardiovascular diseases, its preparation and use |
| 01/12/2011 | CN1980898B Nucleoside derivatives and therapeutic uses therof |
| 01/12/2011 | CN1957937B Dispersion tablet of Glucurolactone, and preparation method |
| 01/12/2011 | CN1950371B Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands |
| 01/12/2011 | CN1939415B Medicinal composition for infection resistance, virus resistance and antipyreti effect |
| 01/12/2011 | CN1933850B Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants |
| 01/12/2011 | CN1922157B Benzo[d]isoxazol-3-ol daao inhibitors |
| 01/12/2011 | CN1909928B Complexes having adjuvant activity |
| 01/12/2011 | CN1895260B Sucrose-ferri aseptic powdery injection and its preparation |
| 01/12/2011 | CN1893937B Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity |
| 01/12/2011 | CN1872030B Drop pills of anticancer drugs, and preparation method |
| 01/12/2011 | CN1856313B Therapeutic compounds |
| 01/12/2011 | CN1826360B Thermosensitive polymers for therapeutic use and methods of preparation |
| 01/12/2011 | CN1824315B Synergistic therapeutic compositions and methods |
| 01/12/2011 | CN1823771B FK506 oral medicinal composition |
| 01/12/2011 | CN1816548B Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 01/12/2011 | CN1791398B Treating or preventing hot flashes using prodrugs of GABA analogs |
| 01/12/2011 | CN1785251B Powder injection containing red-rooted salvia |
| 01/12/2011 | CN1738595B Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters |
| 01/12/2011 | CN101946001A Polypeptide-nucleic acid conjugates and uses thereof |
| 01/12/2011 | CN101945885A Steroid derivatives acting as glucocorticosteroid receptor agonists |
| 01/12/2011 | CN101945877A Pyrrolopyrazine kinase inhibitors |
| 01/12/2011 | CN101945876A Nitrogen-containing bicyclic compounds active on chronic pain conditions |
| 01/12/2011 | CN101945875A Azaindolizines and methods of use |
| 01/12/2011 | CN101945874A 3-substituted-4-0x0-3, 4-dihydro-imidazo- [5, 1-d] [1,2,3,5] -tetrazine-8-carboxylic acid amides as anticancer agents |
| 01/12/2011 | CN101945873A Stable crystal of beta-lactam compound |
| 01/12/2011 | CN101945872A (1-azinone) -substituted pyridoindoles as mch antagonists |
| 01/12/2011 | CN101945871A Imidazo [1,2-a] pyridine compounds |
| 01/12/2011 | CN101945870A 5-anilinoimidazopyridines and methods of use |
| 01/12/2011 | CN101945868A Gamma secretase modulators |
| 01/12/2011 | CN101945867A Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors |
| 01/12/2011 | CN101945866A Aminothiazoles and their uses |
| 01/12/2011 | CN101945865A 1, 2, 4 -oxadiazole compounds for the treatment of autoimmune diseases |
| 01/12/2011 | CN101945864A Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) |
| 01/12/2011 | CN101945863A Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) |
| 01/12/2011 | CN101945862A Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 01/12/2011 | CN101945859A Bis-(sulfonylamino) derivatives in therapy |
| 01/12/2011 | CN101945858A Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/12/2011 | CN101945856A Herbicidal pyridazinone derivatives |
| 01/12/2011 | CN101945855A Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 01/12/2011 | CN101945853A Selective androgen receptor modulators (sarms) and uses thereof |
| 01/12/2011 | CN101945852A Azetidine derivatives, their preparation and their application in therapy |
| 01/12/2011 | CN101945851A Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors |